Psychiatry 2008 - September 2008 - (Page 28) FIGURE 2. Neural circuitry of MDD and DBS targets. Circuitry is divided into cortical and limbic compartments with links between amygdala, ACG, and HPA axis forming a modulatory circuit between the cortical and limbic compartments. DBS interventions for MDD target nodes within the limbic compartment. KEY: DBS: deep brain stimulation; MDD: major depressive disorder; HPA: hypothalamic-pituitary axis have been implicated in symptoms of OCD involving feedback loops between the cortex, striatum, and thalamus. A multicircuit hypothesis of OCD states that the primary pathogenic mechanism is a dysregulation of the basal ganglia and limbic striatal circuitry working in concert with portions of the orbitofrontal and anterior cingulate cortex. Simplified, one can postulate the following three components to this model (Figure 1):2 1. A positive feedback loop from the orbital and prefrontal cortex to the thalamus via the anterior limb of the internal capsule. This cortico-thalamic pathway is 28 Psychiatry 2008 [SEPTEMBER] excitatory and bidirectional. 2. A circuit linking the orbitofrontal cortex, caudate nucleus, globus pallidus, and the thalamus, known as the CSTC loop (cortexstriatum-thalamus-cortex). The overall output of this pathway is inhibitory and is thought to serve as a counterweight to the excitatory positive feedback loop as described in this article. This inhibitory pathway also receives serotonergic projections from the midbrain into the striatum. 3. A component linking portions of the limbic system, including the hippocampus, mammillary bodies and fornix, to the thalamus to the anterior cingulate cortex (ACC). These connections are hypothesized to contribute to the affective anxiety component of OCD symptoms. Bringing together these three components of the circuit, OCD symptoms occur when there is an abnormal positive feedback in the orbito-fronto-thalamic circuit (# 1) that is, in turn, inadequately inhibited or modulated by the CSTC loop (# 2). One would then expect OCD symptoms to appear when the CSTC loop is abnormally decreased (too little inhibition), or when orbitofronto-thalamic activity is abnormally increased (too much excitation).
Table of Contents Feed for the Digital Edition of Psychiatry 2008 - September 2008 Psychiatry 2008 - September 2008 Editor’s Message Editorial Advisory Board Contents Psych Rx Letters to the Editor Use of Benzodiazepines in the Treatment of Anxiety Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder Risperidone Long-acting Injections: Successful Alternative Deltoid Muscle Injections for Refractory Schizophrenia Alcohol/Substance Misuse and Treatment Nonadherence: Fatal Attraction Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting Journal Watch Classified Advertising Information for Authors Psychiatry 2008 - September 2008 Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page Cover1) Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page Cover2) Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page 3) Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page 4) Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page 5) Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page 6) Psychiatry 2008 - September 2008 - Psychiatry 2008 - September 2008 (Page 7) Psychiatry 2008 - September 2008 - Editor’s Message (Page 8) Psychiatry 2008 - September 2008 - Editor’s Message (Page 9) Psychiatry 2008 - September 2008 - Editorial Advisory Board (Page 10) Psychiatry 2008 - September 2008 - Editorial Advisory Board (Page 11) Psychiatry 2008 - September 2008 - Contents (Page 12) Psychiatry 2008 - September 2008 - Contents (Page 13) Psychiatry 2008 - September 2008 - Contents (Page 14) Psychiatry 2008 - September 2008 - Psych Rx (Page 15) Psychiatry 2008 - September 2008 - Psych Rx (Page 16) Psychiatry 2008 - September 2008 - Psych Rx (Page 17) Psychiatry 2008 - September 2008 - Psych Rx (Page 18) Psychiatry 2008 - September 2008 - Letters to the Editor (Page 19) Psychiatry 2008 - September 2008 - Letters to the Editor (Page 20) Psychiatry 2008 - September 2008 - Use of Benzodiazepines in the Treatment of Anxiety (Page 21) Psychiatry 2008 - September 2008 - Use of Benzodiazepines in the Treatment of Anxiety (Page 22) Psychiatry 2008 - September 2008 - Use of Benzodiazepines in the Treatment of Anxiety (Page 23) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 24) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 25) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 26) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 27) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 28) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 29) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 30) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 31) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 32) Psychiatry 2008 - September 2008 - Functional Neurosurgery in the Treatment of Severe Obsessive Compulsive Disorder and Major Depression: Overview of Disease Circuits and Therapeutic Targeting for the Clinician (Page 33) Psychiatry 2008 - September 2008 - Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder (Page 34) Psychiatry 2008 - September 2008 - Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder (Page 35) Psychiatry 2008 - September 2008 - Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder (Page 36) Psychiatry 2008 - September 2008 - Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder (Page 37) Psychiatry 2008 - September 2008 - Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder (Page 38) Psychiatry 2008 - September 2008 - Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder (Page 39) Psychiatry 2008 - September 2008 - Risperidone Long-acting Injections: Successful Alternative Deltoid Muscle Injections for Refractory Schizophrenia (Page 40) Psychiatry 2008 - September 2008 - Risperidone Long-acting Injections: Successful Alternative Deltoid Muscle Injections for Refractory Schizophrenia (Page 41) Psychiatry 2008 - September 2008 - Risperidone Long-acting Injections: Successful Alternative Deltoid Muscle Injections for Refractory Schizophrenia (Page 42) Psychiatry 2008 - September 2008 - Alcohol/Substance Misuse and Treatment Nonadherence: Fatal Attraction (Page 43) Psychiatry 2008 - September 2008 - Alcohol/Substance Misuse and Treatment Nonadherence: Fatal Attraction (Page 44) Psychiatry 2008 - September 2008 - Alcohol/Substance Misuse and Treatment Nonadherence: Fatal Attraction (Page 45) Psychiatry 2008 - September 2008 - Alcohol/Substance Misuse and Treatment Nonadherence: Fatal Attraction (Page 46) Psychiatry 2008 - September 2008 - Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting (Page 47) Psychiatry 2008 - September 2008 - Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting (Page 48) Psychiatry 2008 - September 2008 - Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting (Page 49) Psychiatry 2008 - September 2008 - Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting (Page 50) Psychiatry 2008 - September 2008 - Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting (Page 51) Psychiatry 2008 - September 2008 - Journal Watch (Page 52) Psychiatry 2008 - September 2008 - Journal Watch (Page 53) Psychiatry 2008 - September 2008 - Journal Watch (Page 54) Psychiatry 2008 - September 2008 - Classified Advertising (Page 55) Psychiatry 2008 - September 2008 - Information for Authors (Page 56) Psychiatry 2008 - September 2008 - Information for Authors (Page 57) Psychiatry 2008 - September 2008 - Information for Authors (Page 58) Psychiatry 2008 - September 2008 - Information for Authors (Page Cover3) Psychiatry 2008 - September 2008 - Information for Authors (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.